Healthcare costs for metastatic castration‑resistant prostate cancer patients treated with abiraterone or enzalutamide

Dikshyanta Rana, Claudia Geue, Kelly Baillie, Jiafeng Pan, Tanja Mueller, Jennifer Laskey, Marion Bennie, Julie Clarke, Robert Jones, Ailsa Brown, Olivia Wu

Research output: Contribution to journal › Article › peer-review

1 Citation (Scopus)
22 Downloads (Pure)

Fingerprint

Dive into the research topics of 'Healthcare costs for metastatic castration‑resistant prostate cancer patients treated with abiraterone or enzalutamide'. Together they form a unique fingerprint.

Medicine and Dentistry

Pharmacology, Toxicology and Pharmaceutical Science